Israel Biotech Fund
Dr. Cabilly has vast experience in identifying, funding, and engaging in business development activities of Israeli biotech companies. Dr. Cabilly received his Ph.D. in molecular cell biology from Tel Aviv University, where he focused his research on neurodegenerative disease, and several of his articles have been published in well-known scientific journals.
This person is not in any offices
Israel Biotech Fund
Israel Biotech Fund seeks high-value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies. Their key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide their portfolio companies with hands-on guidance and support.